GL1X · GenesisL1 explorer

MolNFT v1 · #157567 · protein

Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents

6N3N · Eif-2-alpha kinase GCN2,EIF-2-alpha kinase GCN2: “Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents”. X-ray diffraction, 1 ligand (KA4), 2 pockets (best druggability 0.72). MolNFT v1…

PDB
6N3N
Type
protein
Length
242 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Eif-2-alpha kinase GCN2,EIF-2-alpha kinase GCN2
EC
2.7.11.1
UniProt
Q9P2K8
Ligands
KA4
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEif-2-alpha kinase GCN2,EIF-2-alpha kinase GCN2 (EC 2.7.11.1)protein24237% helix, 19% strandQ9P2K8

Ligands and binding sites

  • KA4 · N-{3-[(2-aminopyrimidin-5-yl)ethynyl]-2,4-difluorophenyl}-2,5-dichloro-3-(hydroxymethyl)benzene-1-sulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13460.720.8441KA4
2670.460.8213empty

Compared structures

  • 6N3N · Identification of novel, potent and selective GCN2 inhibitors as first-in-class… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9P2K8 · AlphaFold monomer V2.0 prediction for eif-2-alpha kinase GCN2 (Q9P2K8) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.